POC diagnostics market worth $ 81.37 billion at 9.4% per

Pune, India, September 16, 2021 (GLOBE NEWSWIRE) – The world POC Diagnostics Market The size is expected to gain ground reaching $ 81.37 billion by 2028 while posting a 9.4% CAGR between 2021 and 2028. This information is published by Fortune Business Insights in a report titled “POC Diagnostics Market, 2021 -2028 ”. The report further mentions that the market amounted to USD 34.49 billion in 2020. Factors such as the increasing prevalence of chronic diseases and the increasing emphasis on the introduction of advanced test kits will promote the growth of the market . According to data from the United Nations Program on HIV / AIDS (UNAIDS), in 2019, approximately 38 million people were diagnosed with HIV / AIDS.

The outbreak of the coronavirus has put massive economic pressure on industries in various countries. We understand that this health emergency has had a negative impact on various sectors around the world. Growing support from governments and several companies can help fight this highly infectious virus. Some industries are struggling and others are thriving. It is estimated that almost all sectors are affected by this pandemic.

Important developments in the POC Diagnostics Market industry include:

june 2020 – Celltrion Group launched a SARS-CoV-2 point-of-care antigen diagnostic kit. Launch Expected to Help Solidify Position in Managing and Treating COVID-19 Diagnosis and Treatment Globally

Request a sample copy of the research report:


What does the report include?

The market report comprises detailed qualitative and quantitative analysis of the market and focuses on crucial aspects such as materials, major companies, applications, and products. In addition, the report offers an overview of the latest trends and highlights the main developments in the industry. The report further includes historical data and revenue growth forecast at global, regional and country level. It analyzes the latest industry dynamics and opportunities to impact the market growth between 2021 and 2028.

Click here to learn about the short and long term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/point-of-care-diagnostics-market-101072

Increased focus on launching innovative diagnostic devices to propel market growth

The increasing number of chronic diseases such as infectious diseases, diabetes, HIV, etc., is pushing several pharmaceutical companies to introduce innovative test kits. This should stimulate demand for the product. For example, in June 2019, Abbott launched the Afinion HbA1c Dx test, a one-of-a-kind point-of-care test approved by the U.S. Food and Drug Administration (FDA) to detect diabetes. The continued efforts by major companies to develop advanced POC kits are therefore expected to contribute to the growth of the global POC diagnostics market during the forecast period.

Do you have a question ? Ask our experts:


North America remains dominant; Growing adoption of advanced POC kits to promote growth

Among all regions, North America is expected to remain at the forefront and hold the highest position in the market for years to come. This is due to the increasing adoption of advanced point-of-care (POC) diagnostic kits to detect infectious diseases in the region during the forecast period. North America was worth $ 14.10 billion in 2020.

Europe is expected to occupy the second position in the market during the forecast period. This is due to the growing investment in the development of point-of-service diagnostics (POC) in countries like Germany, Spain and France. For example, in November 2019, Linear Diagnostics secured an investment of $ 2.6 million to develop an advanced POC optical diagnostic test platform to detect sexually transmitted diseases.

The list of manufacturers in the POC Diagnostics market includes:

  • Hoffmann-La Roche SA
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Quest Diagnostics Incorporated
  • Comics
  • bioMérieux SA
  • Cardinal Health, Inc.
  • Mesa Biotech
  • Cepheid
  • Trinity Biotech
  • Quidel Corporation
  • Bio-Rad Laboratories inc.
  • Other players

Get your personalized research report:


Global segmentation of the POC diagnostics market:

  • introduction
    • Market scope
    • Market segmentation
    • Market methodology
    • Definitions and assumptions
  • Abstract
  • Market dynamics
    • Market factors
    • Market constraints
    • Market opportunities
  • Global POC Diagnostics Market Analysis, Outlook and Forecast, 2017-2028
  • Main conclusions / Summary
  • Market analysis, information and forecasts – by product
    • Blood glucose monitoring
    • Infectious diseases
    • Cardiometabolic diseases
    • Pregnancy and infertility tests
    • Hematology tests
    • Others
  • Market analysis, information and forecasts – by end user
    • Hospital bedside
    • Doctor’s office laboratory
    • Retail and emergency care clinics
    • Home care / Self-test
  • Market analysis, information and forecasts – by geography
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

Speak to a point-of-care diagnostics industry analyst:



  • Details such as revenue, market share, strategies, growth rate, products and their pricing by region / country for all major companies
  • Details regarding prevalence, incidence, number of patients, distribution of patients, average price of treatment, etc.
  • Number of end-user installations by region / country and average annual spend or device purchases by type of end-user installations
  • Number of procedures and average price of procedures
  • Replacement rate and pricing of capital goods
  • Market dynamics versus target market – Drivers, constraints, trends and opportunities
  • Market and technology trends, new product developments, product pipeline.

About Us:

Fortune Business Insights ™ delivers expert business analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions to our clients, helping them meet the specific challenges of their businesses. Our goal is to provide our clients with comprehensive market information, giving them a granular overview of the market in which they operate.

Our reports contain a unique blend of tangible information and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use cutting-edge research tools and techniques to compile comprehensive market research, interspersed with relevant data.

At Fortune Business Insights ™, we aim to highlight the most lucrative growth opportunities for our clients. We therefore offer recommendations allowing them to navigate more easily in technological and market-related developments. Our consulting services are designed to help organizations identify hidden opportunities and understand dominant competitive challenges.

Contact us:

Fortune Business Insights ™ Pvt. Ltd.

308, Supreme Headquarters,

Investigation n ° 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


United States: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]

Fortune Business Insights ™

LinkedIn | Twitter | Blogs

Source link

About Bradley J. Bridges

Check Also

HIV Associated Lipodystrophy Syndrome Treatment Market Size, Trends 2021, Growth, Share, Trends and Forecast to 2028

New Jersey, United States, – Global HIV Associated Lipodystrophy Syndrome Treatment market comprises market share, …